The Centers for Disease Control and Prevention Advisory Committee on Immunization Practice and the American College of Obstetricians and Gynecologists Committee on Obstetric Practice recommend that all women who are pregnant between October and May receive inactive influenza vaccine.
The Centers for Disease Control and Prevention Advisory Committee on Immunization Practice and the American College of Obstetricians and Gynecologists (ACOG) Committee on Obstetric Practice recommend that all women who are pregnant between October and May receive inactivated influenza vaccine.
In a published statement, ACOG advises that preventing the flu during pregnancy is essential to prenatal care. Immune system changes during pregnancy place pregnant women at increased risk for serious complications of influenza. In addition to protecting pregnant women, maternal vaccination provides protection for newborns who cannot be vaccinated until they reach 6 months of age.
Vaccination early in flu season is optimal, but the vaccine can be given anytime, regardless of trimester. ACOG advises the use of the inactivated flu vaccine; the live attenuated version of the flu vaccine-the nasal mist-is contraindicated during pregnancy. No studies to date demonstrate any adverse consequence of the inactivated version for pregnant women or their offspring. The statement notes that there is no scientific evidence that thimerosal, a mercury-containing preservative used in some vaccines, causes harm to pregnant women or their infants.
Mosie Baby Kit receives class 2 FDA clearance for intravaginal insemination
December 6th 2023Discover how Mosie Baby's at-home insemination kit, the first FDA-cleared of its kind, empowers individuals facing infertility challenges with an effective, easy-to-use solution for intravaginal insemination.
Read More
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive
December 5th 2023Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.
Read More
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
How plasma biomarkers illuminate brain health in women with HIV
December 4th 2023Discoveries from a comprehensive study reveal specific plasma biomarkers that may serve as indicators of neurological well-being in individuals living with HIV, shedding light on potential links to Alzheimer's disease and emphasizing the importance of early detection for improved outcomes.
Read More